The history of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical sector. While its initial success and creation of vast in sales, the patent end has opened the way for competing medications, significantly eroding income opportunities. This shift raises here concerns about the conti